Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,000 shares at $12.71 ($254K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($254k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.71 | 10,000 | $127K | 50.0% |
| 2 | $12.71 | 10,000 | $127K | 50.0% |
| Total | $12.71 avg | 20,000 | $254K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |